George A. Yendewa

1.1k total citations
54 papers, 372 citations indexed

About

George A. Yendewa is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, George A. Yendewa has authored 54 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 26 papers in Epidemiology and 12 papers in Hepatology. Recurrent topics in George A. Yendewa's work include HIV/AIDS Research and Interventions (15 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (11 papers). George A. Yendewa is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (11 papers). George A. Yendewa collaborates with scholars based in United States, Sierra Leone and United Kingdom. George A. Yendewa's co-authors include Robert A. Salata, Sulaiman Lakoh, Gibrilla F. Deen, Foday Sahr, Eva Poveda, Darlinda F. Jiba, Grace A. McComsey, Olukemi Adekanmbi, Jaime A. Pérez and Ángel Salgado‐Barreira and has published in prestigious journals such as Clinical Infectious Diseases, Science Advances and Frontiers in Immunology.

In The Last Decade

George A. Yendewa

46 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Yendewa United States 12 223 167 64 52 52 54 372
Rachel Hart-Malloy United States 9 293 1.3× 232 1.4× 42 0.7× 80 1.5× 21 0.4× 20 505
Christina Yek United States 10 193 0.9× 114 0.7× 56 0.9× 62 1.2× 16 0.3× 32 407
Darlinda F. Jiba Sierra Leone 9 148 0.7× 135 0.8× 28 0.4× 22 0.4× 24 0.5× 22 235
Mahesh Patel United States 11 216 1.0× 91 0.5× 42 0.7× 63 1.2× 29 0.6× 26 442
Rachel Rodin Canada 8 133 0.6× 295 1.8× 13 0.2× 30 0.6× 34 0.7× 19 427
Laura Ciaffi Cameroon 15 382 1.7× 236 1.4× 59 0.9× 172 3.3× 71 1.4× 35 547
Wanitchaya Kittikraisak United States 13 581 2.6× 554 3.3× 35 0.5× 59 1.1× 18 0.3× 38 779
Elizabeth Petzold United States 11 382 1.7× 130 0.8× 10 0.2× 216 4.2× 82 1.6× 19 557
Haruna Jibril United States 13 217 1.0× 103 0.6× 46 0.7× 25 0.5× 28 0.5× 21 429
Andrea Gabbuti Italy 12 273 1.2× 238 1.4× 121 1.9× 119 2.3× 73 1.4× 14 481

Countries citing papers authored by George A. Yendewa

Since Specialization
Citations

This map shows the geographic impact of George A. Yendewa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Yendewa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Yendewa more than expected).

Fields of papers citing papers by George A. Yendewa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Yendewa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Yendewa. The network helps show where George A. Yendewa may publish in the future.

Co-authorship network of co-authors of George A. Yendewa

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Yendewa. A scholar is included among the top collaborators of George A. Yendewa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Yendewa. George A. Yendewa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davy-Méndez, Thibaut, Sonia Napravnik, Brenna Hogan, et al.. (2025). Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018. Clinical Infectious Diseases. 81(4). 806–814.
2.
Freeman, Michael L., Brian Clagett, Konstantin Leskov, et al.. (2025). Interleukin-2 is a potent latency reversal agent in people with treated HIV-1. Science Advances. 11(51). eaea4268–eaea4268.
3.
Brown, Erik C., et al.. (2025). Development and implementation of an electronic health record system for use in humanitarian emergencies, disaster response, and conflict zones. PLOS Global Public Health. 5(1). e0003124–e0003124. 1 indexed citations
4.
Yendewa, George A., Jaime A. Pérez, Nirav Patil, & Grace A. McComsey. (2024). Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study. Frontiers in Immunology. 15. 1297195–1297195. 8 indexed citations
5.
Brown, Erik C., et al.. (2024). Implementation of an Electronic Health Record System for Use Inhumanitarian Emergencies, Disaster Response, and Conflict Zones. Disaster Medicine and Public Health Preparedness. 18.
6.
7.
8.
Lakoh, Sulaiman, Olukemi Adekanmbi, Darlinda F. Jiba, et al.. (2023). Impact of COVID-19 on the Utilization of HIV Testing and Linkage Services in Sierra Leone: Experience from Three Public Health Facilities in Freetown. AIDS and Behavior. 28(4). 1235–1243. 3 indexed citations
9.
Yendewa, George A., et al.. (2023). Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale. Journal of Viral Hepatitis. 30(7). 621–629. 1 indexed citations
10.
11.
Castelnuovo, Barbara, et al.. (2023). Prevalence of Cardiometabolic Disease Risk Factors in People with HIV Initiating Anti-retroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda. Open Forum Infectious Diseases. 10(6). ofad241–ofad241. 9 indexed citations
12.
Lakoh, Sulaiman, Darlinda F. Jiba, Olukemi Adekanmbi, et al.. (2023). Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: A cross-sectional study. PLoS neglected tropical diseases. 17(7). e0011284–e0011284. 8 indexed citations
13.
Song, Jin‐Wen, Guang Yang, Wei Sun, et al.. (2023). HIV viral suppression at different thresholds and duration of treatment in the dolutegravir treatment era in Sierra Leone: a nationwide survey. Virology Journal. 20(1). 279–279. 1 indexed citations
14.
Yendewa, George A., Peter James, Amir M. Mohareb, et al.. (2023). Determinants of incomplete childhood hepatitis B vaccination in Sierra Leone, Liberia, and Guinea: Analysis of national surveys (2018–2020). Epidemiology and Infection. 151. e193–e193. 5 indexed citations
15.
James, Peter, Gibrilla F. Deen, James B. Russell, et al.. (2022). COVID-19 Vaccine Hesitancy among Healthcare Workers and Trainees in Freetown, Sierra Leone: A Cross-Sectional Study. Vaccines. 10(5). 757–757. 18 indexed citations
16.
17.
Lakoh, Sulaiman, Darlinda F. Jiba, Wadzani Gashau, et al.. (2021). Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study. BMC Gastroenterology. 21(1). 320–320. 5 indexed citations
18.
Yendewa, George A., Sulaiman Lakoh, Hannah Lawrence, et al.. (2020). Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study. International Journal of Infectious Diseases. 102. 45–52. 14 indexed citations
19.
Yendewa, George A., Foday Sahr, Antonio Aguilera, et al.. (2019). Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone. American Journal of Tropical Medicine and Hygiene. 100(6). 1521–1524. 12 indexed citations
20.
Poveda, Eva, et al.. (2018). HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic. PubMed. 20(2). 104–113. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Hart-Malloy Breakdown of academic impact, for papers by Christina Yek Breakdown of academic impact, for papers by Darlinda F. Jiba Breakdown of academic impact, for papers by Mahesh Patel Breakdown of academic impact, for papers by Rachel Rodin Breakdown of academic impact, for papers by Laura Ciaffi Breakdown of academic impact, for papers by Wanitchaya Kittikraisak Breakdown of academic impact, for papers by Elizabeth Petzold Breakdown of academic impact, for papers by Haruna Jibril Breakdown of academic impact, for papers by Andrea Gabbuti
Rankless by CCL
2026